Thermal ablation of hepatocellular carcinoma in patients with abnormal coagulation function

References

• Torre LA, Bray F, Siegel RL, et al. (2015). Global cancer statistics, 2012. CA Cancer J Clin 65:87–108.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. (2011). Management of hepatocellular carcinoma: an update. Hepatology 53:1020–2.
   PubMed Web of Science ®Google Scholar
• Bruix J, Gores GJ, Mazzaferro V. (2014). Hepatocellular carcinoma: clinical frontiers and perspectives. Gut 63:844–55.
   PubMed Web of Science ®Google Scholar
• De Pietri L, Bianchini M, Montalti R, et al. (2016). Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: a randomized, controlled trial. Hepatology 63:566–73.
   PubMed Web of Science ®Google Scholar
• Tejima K, Masuzaki R, Ikeda H, et al. (2010). Thrombocytopenia is more severe in patients with advanced chronic hepatitis C than B with the same grade of liver stiffness and splenomegaly. J Gastroenterol 45:876–84.
   PubMed Web of Science ®Google Scholar
• Andriulli A, Tripodi A, Angeli P, et al. (2016). Hemostatic balance in patients with liver cirrhosis: report of a consensus conference. Dig Liver Dis 48:455–67.
   PubMedGoogle Scholar
• Ghadimi K, Levy JH, Welsby IJ. (2016). Perioperative management of the bleeding patient. Br J Anaesth 117:iii18–30.
   PubMed Web of Science ®Google Scholar
• Lee MW, Raman SS, Asvadi NH, et al. (2017). Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: a ten year intention-to-treat analysis. Hepatology 65:1979–90.
   PubMed Web of Science ®Google Scholar
• Qi X, Wang D, Su C, et al. (2015). Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: a systematic review and meta-analysis. Oncotarget 6:18715–33.
   PubMed Web of Science ®Google Scholar
• Taner T, Nagorney DM, Tefferi A, et al. (2012). Splenectomy for massive splenomegaly: long-term results and risks for mortality. Ann Surg 258:1034–9.
   Web of Science ®Google Scholar
• Ahuja C, Farsad K, Chadha M. (2015). An overview of splenic embolization. AJR Am J Roentgenol 205:720–5.
   PubMed Web of Science ®Google Scholar
• Han J-B, Kong F-W, Ding H, et al. (2017). Hepatectomy combined with microwave ablation of the spleen for treatment of hepatocellular carcinoma complicated with splenomegaly: a retrospective study. Mol Clin Oncol 6:204–8.
   PubMedGoogle Scholar
• Wang C, Wang HH, Yang W, et al. (2015). Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology 61:1579–90.
   PubMed Web of Science ®Google Scholar
• Lee DH, Lee JM, Lee JY, et al. (2014). Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis. Radiology 270:900–9.
   PubMed Web of Science ®Google Scholar
• Fonseca AZ, Santin S, Gomes LGL, et al. (2014). Complications of radiofrequency ablation of hepatic tumors: frequency and risk factors. World J Hepatol 6:107–13.
   PubMedGoogle Scholar
• Bertot LC, Sato M, Tateishi R, et al. (2011). Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review. Eur Radiol 21:2584–96.
   PubMed Web of Science ®Google Scholar
• Goto E, Tateishi R, Shiina S, et al. (2010). Hemorrhagic complications of percutaneous radiofrequency ablation for liver tumors. J Clin Gastroenterol 44:374–80.
   PubMed Web of Science ®Google Scholar
• Kim Y, Lim HK, Rhim H, et al. (2013). Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol 58:89–97.
   PubMed Web of Science ®Google Scholar
• Basili S, Raparelli V, Violi F. (2010). The coagulopathy of chronic liver disease: is there a causal relationship with bleeding? Yes. Eur J Intern Med 21:62–4.
   PubMed Web of Science ®Google Scholar
• Chinese Society of Liver Cancer, Chinese Anti-Cancer Association; Chinese Society of Clinical Oncology, Chinese Anti-Cancer Association; Liver Cancer Study Group, Chinese Society of Hepatology, Chinese Medical Association (2011). Expert consensus on the norms of local ablation therapy for hepatocellular carcinoma. Chinese J Hepatol 19:257–9.
   PubMedGoogle Scholar
• Rossi S, Ravetta V, Rosa L, et al. (2011). Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study. Hepatology 53:136–47.
   PubMed Web of Science ®Google Scholar
• Livraghi T, Solbiati L, Meloni MF, et al. (2003). Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 226:441–51.
   PubMed Web of Science ®Google Scholar
• Rhim H, Chintapalli KN, Wood BJ, et al. (2004). Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics 24:41.
   PubMed Web of Science ®Google Scholar
• Rhim H, Lim HK, Kim YS, et al. (2008). Radiofrequency ablation of hepatic tumors: lessons learned from 3000 procedures. J Gastroenterol Hepatol 23:1492–500.
   PubMed Web of Science ®Google Scholar
• Mulier DS, Mulier P, Ni Y, et al. (2002). Complications of radiofrequency coagulation of liver tumours. Br J Surg 89:1206–22.
   PubMed Web of Science ®Google Scholar
• Garcia-tsao G, Bosch J. (2010). Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med 362:823–32.
   PubMed Web of Science ®Google Scholar
• LaBreque D, Dite P, Fried M, Gangl A, Kan AG, Esophageal varices. World Gastroenterology Organisation Global Guidelines; 2014, 2–3.
   Google Scholar
• Van Meer S, De Man RA, Coenraad MJ, et al. (2015). Surveillance for hepatocellular carcinoma is associated with increased survival: results from a large cohort in the Netherlands. J Hepatol 63:1156–63.
   PubMed Web of Science ®Google Scholar
• Yu J, Yu X-L, Han Z-Y, et al. (2017). Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial. Gut, 2016,66(6):gutjnl-2016-312629.
   Web of Science ®Google Scholar
• Zhou L, Kuang M, Xu Z, et al. (2015). Contrast-enhanced sonographically guided thermal ablation for treatment of solid-organ hemorrhage: preliminary clinical results. J Ultrasound Med 34:907–15.
   PubMed Web of Science ®Google Scholar
• Miele V, Piccolo CL, Galluzzo M, et al. (2016). Contrast-enhanced ultrasound (CEUS) in blunt abdominal trauma. Br J Radiol 89:20150823
   PubMed Web of Science ®Google Scholar
• Wu XY, Shi XL, Zhou JX, et al. (2012). Life-threatening hemorrhage after liver radiofrequency ablation successfully controlled by transarterial embolization. World J Hepatol 4:419–21.
   PubMedGoogle Scholar
• Maroulis I, Spyropoulos C, Kalogeropoulou C, Karavias D. (2013). Use of radiofrequency ablation for controlling liver hemorrhage in the emergency setting; report of two cases and review of the literature. Ulus Travma Ve Acil Cerrahi Derg 19:167–72.
   PubMed Web of Science ®Google Scholar
• Xu Y, Shen Q, Liu P, et al. (2017). Microwave ablation for the treatment of hepatocellular carcinoma that met up-to-seven criteria: feasibility, local efficacy and long-term outcomes. Eur Radiol 27:3877–87.
   PubMed Web of Science ®Google Scholar
• Peng Z-W, Lin X-J, Zhang Y-J, et al. (2012). Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study. Radiology 262:1022–33.
   PubMed Web of Science ®Google Scholar